Pharmaceutical Peptide cas204656-20-2 Raw Powder Liraglutide GLP-1 Analogue 3mg 5mg 10mg vials

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates secretion.

Liraglutide is a once-daily injectable derivative of the human incretin (metabolic hormone) glucagon-like peptide-1 (GLP-1), for the treatment of type 2 diabetes or obesity.
Type 2 diabetes
Liraglutide improves control of blood glucose. It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion.
In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes:
It acts in a glucose-dependent manner, meaning it will stimulate secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia.
It has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies).
It decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride.
It lowers blood triglyceride levels.

Product Specification:

Product Photo:

Other Products:

Haikou Mingheng Biotechnology Co., Ltd, is a pioneering force in the biotechnology sector. At the core of our operations is the unwavering commitment to our guiding principles: "Quality First, Service Supreme."

Business Philosophy:
"Quality First, Service Supreme" encapsulates our business philosophy. We firmly believe that prioritizing quality in all aspects of our operations and providing exceptional service form the foundation for enduring success.

Key Products:
Our primary focus encompasses a range of products, including weight loss peptides, medicinal peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Semaglutide, Tirzepatide, Retatrutide, and others.

Mission:
Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.

Customized Peptides:
In addition to our standard product line, we specialize in crafting customized peptides tailored to meet the unique needs of our diverse clientele.

Future Vision:
As we move forward, Haikou Mingheng Biotechnology Co., Ltd. is poised for continued growth and innovation. We are committed to expanding our product portfolio, staying at the forefront of technological advancements, and exceeding the expectations of our valued clients.

At Haikou Mingheng Biotechnology Co., Ltd, we are not just shaping the future of biotechnology; we are pioneering a path towards a healthier and more sustainable world.